Entod appoints Prof Vivek Padgaonkar as non-executive independent director, ET HealthWorld

New Delhi: Entod Pharmaceuticals has appointed Prof Vivek Padgaonkar, Former Director, OPPI (Project & Policy), as a non-executive independent director. Prof Padgaonkar brings a wealth of experience from his extensive work with various lobbying and think-tank organisations on healthcare issues. His collaborations with several government ministries have significantly shaped current pharmaceutical policies. He also holds independent directorships at Martin & Harris Labs Ltd, Bervin Investment & Leasing Limited, and Juvenor Healthcare.

Prof Padgaonkar expressed, “I am honoured to join Entod Pharmaceuticals and contribute to its mission of driving innovation in the pharmaceutical industry. This is a remarkable opportunity to leverage my experience with a company at the forefront of technological advancements.”

Nikkhil K Masurkar, CEO, Entod Pharmaceuticals, commented, “We are thrilled to welcome Prof Padgaonkar to our board. His extensive experience and respected stature in the industry will be invaluable as we strive to position Entod and the Indian pharmaceutical sector as global leaders in innovation. His insights will be crucial in our ongoing efforts to develop novel solutions using advanced AI technologies, pushing our vision of a future-ready pharmaceutical industry.”